Ribostamicin

Ribostamicin

(IUPAC) ime
(1R,2R,3S,4R,6S)-4,6-diamino-3-hidroksi-2-(β-D-ribofuranoziloksi)cikloheksil 2,6-diamino-2,6-dideoksi-α-D-glukopiranozid
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
Identifikatori
CAS broj	53797-35-6
ATC kod	J01GB10
PubChem[1][2]	5066
UNII	2Q5JOU7T53 Y
ChEMBL[3]	CHEMBL1256830 Y
Hemijski podaci
Formula	C17H34N4O10
Mol. masa	454,47266 g/mol
SMILES	eMolekuli & PubHem
InChI InChI=1S/C17H34N4O10/c18-2-6-10(24)12(26)8(21)16(28-6)30-14-5(20)1-4(19)9(23)15(14)31-17-13(27)11(25)7(3-22)29-17/h4-17,22-27H,1-3,18-21H2 Y Key: NSKGQURZWSPSBC-UHFFFAOYSA-N Y
Sinonimi	(2R,3S,4R,5R,6R)-5-amino-2-(aminometil)-6[(1R,2R,3S,4R,6S)-4,6-diamino-2[(2S,3R,4S,5R)-3,4-dihidroksi-5-(hidroksimetil)oksolan-2-il]oksi3-hidroksicikloheksil]oksi}oksan-3,4-diol
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Ribostamicin je aminoglikozidni antibiotik.

1. ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
2. ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
3. ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit